If you're searching for a Depo Provera injury lawyer, you may be dealing with a serious health condition that you suspect is linked to a medication you relied on. This page summarizes key medical and legal information so you can make informed decisions.
Key Steps to Take:
What You Could Potentially Recover:
Recent epidemiologic research has raised concern about an association between long-term use of injectable medroxyprogesterone acetate and meningioma. A large French nationwide, population-based case‑control study published in The BMJ in 2023 (Bernat et al., 2023) reported that prolonged use (≥1 year) of injectable medroxyprogesterone acetate was associated with a significantly increased risk of intracranial meningioma compared with non‑use. The authors found higher odds ratios with longer duration of use and with certain meningioma locations, suggesting a dose‑ and duration‑related effect.
Many patients allege they were not adequately warned of these potential risks. As a result, lawsuits have been filed against Pfizer and other companies involved in the manufacture and distribution of Depo-Provera, asserting claims such as failure to warn and defective design.
The procedural posture of these cases is evolving. In February 2025, the U.S. Judicial Panel on Multidistrict Litigation centralized federal Depo-Provera meningioma cases into MDL No. 3140 in the Northern District of Florida. MDL consolidation is intended to coordinate pretrial proceedings—such as discovery and motions practice—for efficiency and consistency, while preserving each plaintiff’s individual claim and right to seek damages.
I'm Tim Burd, founder of Justice Hero and Mass Tort Strategies. My team works to connect individuals who may have Depo-Provera‑related injuries with law firms that focus on complex pharmaceutical and medical mass tort litigation.

Explore more about Depo Provera injury lawyer:

Depo-Provera (depot medroxyprogesterone acetate, DMPA) is a long‑acting progestin‑only contraceptive that has been used for decades worldwide. In recent years, new data have intensified scrutiny of its long‑term safety profile, particularly regarding meningioma, a typically benign but potentially serious brain tumor.
Depo-Provera is an intramuscular or subcutaneous injection usually administered every 3 months. It contains medroxyprogesterone acetate, a synthetic progestin. According to the U.S. Food and Drug Administration (FDA) and educational resources such as the Mayo Clinic, it prevents pregnancy primarily by:
While effective and convenient for many users, DMPA has known risks and side effects that are detailed in the FDA‑approved prescribing information. For more on potential complications, see our page on Depo-Provera Adverse Effects.
Meningiomas arise from the meninges, the membranes that surround the brain and spinal cord. Most are histologically benign, but because they can compress adjacent brain structures, they may cause seizures, neurologic deficits, or other significant symptoms, and often require surgery or radiotherapy.
Hormonal influences on meningiomas have been described for decades. As early as the 1980s, researchers reported progesterone and estrogen receptors on many meningioma cells, suggesting that progestins might influence tumor growth.
A key modern source of evidence is a large French nationwide, population‑based study published in The BMJ in 2023 (Bernat et al., “Use of progestogens and risk of intracranial meningioma: nationwide case‑control study,” BMJ 2023;382:e075528). That study found:
This and related research have led regulators and manufacturers in several jurisdictions to review or update product information to include more explicit warnings about potential meningioma risk with certain high‑dose or long‑term progestogen therapies, including injectable medroxyprogesterone acetate.
For a more detailed discussion of the scientific literature, see our article: Does Depo Provera Cause Brain Tumors?
Meningiomas may grow slowly and remain asymptomatic for years. When symptoms occur, they typically reflect the tumor’s size and location. Authoritative sources such as the National Institute of Neurological Disorders and Stroke (NINDS) and major academic medical centers note that common symptoms can include:
If you have used Depo-Provera and experience any of these symptoms, medical evaluation is essential. Imaging studies such as MRI or CT scans are typically required to diagnose or rule out meningioma. Early detection can expand treatment options and may improve outcomes. More details are available on our page about Depo-Provera Brain Tumor Symptoms.
Depo-Provera is also associated with other important long‑term safety concerns. According to the Mayo Clinic and the FDA‑approved labeling for medroxyprogesterone acetate injections, these may include:
More frequent side effects reported with Depo-Provera include changes in menstrual bleeding patterns, weight gain, mood changes (including depression), and headaches. Anyone considering starting, continuing, or discontinuing DMPA should review its risks and benefits with a qualified healthcare professional, with attention to personal medical history and current evidence.
If you were diagnosed with a meningioma after using Depo-Provera, you may have grounds to pursue a product liability claim. These cases commonly assert theories such as failure to warn, design defect, and negligent misrepresentation against manufacturers and related entities. We help explain the information and documentation that attorneys typically evaluate in assessing these claims. For general background, see our Depo Provera Lawsuit page.
Eligibility ultimately depends on the specific facts of your case and the law of your jurisdiction, but many current Depo-Provera meningioma claims share several characteristics:
Attorneys evaluate whether the evidence supports a causal relationship in your case based on current scientific data, your exposure history, and any alternative explanations for your condition.
If you believe Depo-Provera may have contributed to your brain tumor, consider the following steps:
A credible Depo-Provera meningioma claim generally requires well‑organized documentation. Legal teams commonly look for:
The statute of limitations is a legal deadline for filing a lawsuit. If you file after this period expires, your claim can be barred, even if the underlying facts are strong.
Time limits vary by state and by claim type (e.g., personal injury vs. wrongful death). Many jurisdictions, including California, apply a discovery rule to certain latent‑injury claims. Under this rule, the limitations period may begin when you knew or reasonably should have known both that you were injured and that the injury might be attributable to a particular product or conduct.
Because meningiomas may develop and be diagnosed years after exposure, and because the possible association with Depo-Provera has only recently received widespread attention, the discovery rule can be especially important. However, its application is fact‑specific and can be contested.
For that reason, it is important to speak with an experienced Depo Provera injury lawyer as soon as you suspect a connection, so counsel can analyze applicable deadlines in your state and take steps to preserve your claim.
If a lawsuit is successful—through settlement or trial—available compensation may include:
The potential value of any claim depends on multiple factors: the severity of your condition, your age and work history, the extent of your economic losses, your prognosis, and how courts and juries in your jurisdiction have treated similar cases.

Litigation involving pharmaceutical products like Depo-Provera is technically demanding. Defendants are often large manufacturers with substantial legal and scientific resources. An experienced Depo Provera injury lawyer can help you navigate this environment, interpret complex medical and regulatory evidence, and advocate effectively on your behalf. Most firms handling these cases work on a contingency‑fee basis, meaning you do not pay attorney’s fees unless they recover money for you.
A lawyer with experience in drug‑injury and mass‑tort litigation typically:
Working with counsel who regularly handles pharmaceutical and device mass torts offers several practical advantages:
When selecting a Depo Provera injury lawyer, you may want to consider whether the firm has:
The legal landscape for Depo-Provera and its link to meningiomas is evolving quickly. The volume of lawsuits has led to their centralization into a Multidistrict Litigation (MDL), a common practice in complex pharmaceutical cases.
On February 7, 2025, the Judicial Panel on Multidistrict Litigation created the Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability Litigation, designated as MDL No. 3140, in the U.S. District Court for the Northern District of Florida.
An MDL is a procedure to manage complex cases filed in different federal courts that share common questions of fact. The cases are transferred to a single court for coordinated pretrial proceedings. This process:
The common questions in the Depo-Provera MDL are whether the drug causes meningioma and whether defendants like Pfizer failed to adequately warn of the risk, which they have since acknowledged. This raises serious questions about manufacturer accountability. You can find official court information on MDL No. 3140.
The Depo-Provera MDL is not a class action lawsuit. While both involve multiple plaintiffs, there are key distinctions:
This structure preserves the individual nature of your claim while streamlining the legal process. You can learn more about this distinction on our page regarding Class Action Lawsuit Depo Provera.
We recognize that pursuing a potential Depo-Provera claim raises practical and legal questions. Below are responses to some of the issues people most commonly discuss with attorneys. These answers are general in nature and are not a substitute for personalized legal advice.
Most Depo Provera injury lawyer services are provided on a contingency‑fee basis. In this arrangement:
You should carefully review and ask questions about any proposed fee agreement before signing.
In some circumstances, yes. Many states apply a discovery rule to claims involving latent injuries or conditions that develop over time.
The discovery rule generally provides that the statute of limitations does not begin until you knew, or reasonably should have known, that you were injured and that the injury may have been caused by a particular product or conduct. Because meningiomas can grow slowly and because the alleged association with Depo-Provera has only recently been highlighted in major studies and litigation, some individuals are only now making the connection.
The precise application of the discovery rule, tolling doctrines, and other timing issues depends on your state’s law and the specific facts of your case. An experienced Depo Provera injury lawyer can analyze your timeline and advise whether claims may still be timely.
Many patients received generic formulations of depot medroxyprogesterone acetate rather than the brand‑name Depo-Provera. Whether you can bring a claim, and against whom, depends on your state’s product‑liability law.
In some jurisdictions, including California, courts have recognized a doctrine sometimes referred to as “innovator liability.” Under this theory, the brand‑name manufacturer can, in certain circumstances, be held responsible for alleged defects in the warning label even when the injured person used only generic versions, because federal law requires generic labels to mirror the brand‑name labeling.
Not all states recognize innovator liability, and its scope is the subject of ongoing litigation. A lawyer experienced in pharmaceutical cases can review which products you used, where you were prescribed them, and which state’s law is likely to apply in order to assess your options.
The journey from a Depo-Provera prescription to a meningioma diagnosis is one that no woman should have to endure without proper warning or recourse. The scientific evidence linking Depo-Provera to an increased risk of these brain tumors is compelling, and the legal system is now holding manufacturers accountable for their alleged failure to warn.
At Justice Hero, we believe in empowering individuals with the knowledge and legal support needed to stand up against corporate negligence. If you or a loved one has used Depo-Provera and later developed a meningioma, please know that you are not alone, and legal options are available. Our team is dedicated to helping you find the right Depo Provera injury lawyer who can fight for the justice and compensation you deserve.
Taking the next step might seem daunting, but we're here to make it as simple and straightforward as possible. Reach out for a free, confidential case evaluation. Let us help you understand your rights and guide you through the process of seeking accountability.
To begin your path towards justice, you can easily sign up for a Depo-Provera Lawsuit or find comprehensive information on your legal options on our website. We are committed to simplifying complex legal topics and connecting you with the legal advocates who can make a real difference in your life.